Company Filing History:
Years Active: 2021-2024
Title: Innovations of Toshimitsu Endo
Introduction
Toshimitsu Endo is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target specific receptors in the brain. With a total of 2 patents, his work is focused on addressing neurodegenerative diseases.
Latest Patents
Endo's latest patents include innovative compounds that exhibit S1P5 receptor agonistic activity. These compounds are represented by a general formula (V), where all symbols are defined in the specification. They demonstrate an improved balance of agonist activity against the S1P receptor, making them potential therapeutic agents for S1P-mediated diseases such as schizophrenia, Binswanger's disease, and other neurodegenerative conditions.
Career Highlights
Toshimitsu Endo is currently associated with Ono Pharmaceutical Co., Ltd., a leading company in the pharmaceutical industry. His research and inventions have contributed to advancements in treatments for complex neurological disorders.
Collaborations
Endo has collaborated with esteemed colleagues such as Toshihide Watanabe and Kensuke Kusumi. Their combined expertise has further enhanced the research and development of innovative therapeutic solutions.
Conclusion
Toshimitsu Endo's work exemplifies the impact of innovative research in the pharmaceutical field. His contributions are paving the way for new treatments for challenging neurodegenerative diseases.